FLGT
Fulgent Genetics Inc
NASDAQ: FLGT · HEALTHCARE · DIAGNOSTICS & RESEARCH
$15.19
+2.64% today
Updated 2026-04-30
Market cap
$470.46M
P/E ratio
—
P/S ratio
1.46x
EPS (TTM)
$-1.97
Dividend yield
—
52W range
$13 – $31
Volume
0.7M
Fulgent Genetics Inc (FLGT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+71.5%
Last 4 quarters
Revenue YoY growth
+9.3%
Most recent quarter
EPS YoY growth
+300.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-6.6%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-34.9%
2026-02-26
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $0.16 | +365.8% | $23.56 | $15.33 | -34.9% |
| 2025-11-07 | $0.14 | +163.6% | $22.31 | $27.16 | +21.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.06 | $0.16 | +365.8% | $83.34M | +9.3% |
| 2025-09-30 | $-0.22 | $0.14 | +163.6% | $84.07M | +17.2% |
| 2025-06-30 | $-0.18 | $-0.62 | -244.4% | $81.80M | +15.2% |
| 2025-03-31 | $-0.18 | $0.04 | +122.3% | $73.46M | +13.9% |
| 2024-12-31 | $-0.37 | $0.04 | +110.8% | $76.21M | +8.1% |
| 2024-09-30 | $-0.15 | $0.31 | +306.7% | $71.74M | -15.3% |
| 2024-06-30 | $-0.30 | $0.15 | +150.0% | $71.03M | +4.7% |
| 2024-03-31 | $-0.32 | $-0.01 | +96.9% | $64.48M | -2.5% |
| 2023-12-31 | $-0.29 | $0.28 | +196.6% | $70.50M | — |
| 2023-09-30 | $-0.33 | $-0.39 | -18.2% | $84.69M | — |
| 2023-06-30 | $-0.33 | $-0.08 | +75.8% | $67.85M | — |
| 2023-03-31 | $-0.43 | $-0.22 | +48.8% | $66.17M | — |
| 2022-12-31 | $-0.56 | $-0.48 | +14.3% | — | — |
Frequently asked questions
Has Fulgent Genetics Inc beaten earnings estimates?
Fulgent Genetics Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +71.5% over the last 4 quarters.
How does FLGT stock react to earnings?
FLGT stock has moved an average of -6.6% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Fulgent Genetics Inc's revenue growth rate?
Fulgent Genetics Inc reported year-over-year revenue growth of +9.3% in its most recent quarter, with EPS growing +300.0% year-over-year.